Life Sciences

In 2017, the global population has reached 7.6 billion. Mortality – a measure of the annual number of deaths per 1000 people in the world, has steadily declined from 19.2 in 1950-1955 to 7.8 in 2015. In May 2017, the World Health Organization (WHO) released the “World Health Statistics 2017”. According to the report, an estimated 56 million people died worldwide in 2015, of which 40 million died of non-communicable diseases: cardiovascular disease (45%); cancer (22%); chronic respiratory disease (10%); diabetes (4 %). One of the visions of Optima Technology is to make our own contribution to the precise diagnosis and effective treatment of diseases.

The breakthroughs in the fields of of stem cell therapy, gene therapy, next-generation sequencing, genomics and big data have made precision medicine possible. Artificially induced pluripotent stem cells (iPSCs) have similar regenerative capability to embryonic stem cells, evading the risk of rejection reaction and provide new therapy for Alzheimer’s disease, diabetes, arthritis and other diseases. Gene therapy complements them and focuses on the treatment of diseases caused by single gene defects, such as sickle-cell anemia. Next-generation sequencing, especially whole-genome resequencing, has become an important tool for human being to better understand diseases. Precision medicine, based on personalized medicine, combines genome sequencing technology with the cross-application of bioinformatics and big data to develop new medical concepts and medical models that ultimately enable personalized and precise treatment of diseases. No matter at the macro level of human health or at the micro level of corporate development, the above areas will grow vigorously in the future.

Based on the judgment of these technological trends, Optima Technology provides our customers with professional services in the following segments:

  • Stem cell therapy
  • Gene therapy
  • Next-generation sequencing
  • Liquid biopsy
  • Precision medicine

For the above technologies, Optima Technology and its strategic partners can provide our customers consulting services in the entire value chain, from basic research to end applications.